Indivior Pharmaceuticals, Inc. Common Stock
$34.88
-$0.81 (-2.27%)
$34.59Day Range$35.62
Key Statistics
Market Cap
$4.21B
Shares Outstanding
118.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 24, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$35.59
Day High
$35.62
Day Low
$34.59
Volume
4.68M
VWAP
$34.88
Prev Close
$35.69
Transactions
--
Acc. Volume
--
About Indivior Pharmaceuticals, Inc. Common Stock
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
PHARMACEUTICAL PREPARATIONSSIC 2834838 employees10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD, VA, 23235804-379-1090IPO Dec 24, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001625297
- Composite FIGI
- BBG01ZTXFLQ6
- Share Class FIGI
- BBG01ZTXFLX8
- Ticker Root
- INDV
- SIC Code
- 2834
About Indivior Pharmaceuticals, Inc. Common Stock (INDV) Stock
Indivior Pharmaceuticals, Inc. Common Stock (INDV) closed the 2026-09-18 session at $34.88, down 2.27% versus the previous close (-0.81). The stock opened at $35.59 and traded between $34.59 and $35.62 during that session. Session trading volume was 4.7M shares. The volume-weighted average price (VWAP) is $34.88.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Indivior Pharmaceuticals, Inc. Common Stock has a market capitalization of $4.21 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. INDV is listed on the XNAS exchange. The company employs approximately 838 people. Indivior Pharmaceuticals, Inc. Common Stock is headquartered in NORTH CHESTERFIELD, VA. The recorded listing date is 2014-12-24.
On this page you can find market INDV stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.